Cardiac Rehabilitation of Stroke Survivors (SRP-CROSS)
Launched by HACKENSACK MERIDIAN HEALTH · Dec 7, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The SRP-CROSS trial is studying how a special exercise and support program, called cardiac rehabilitation, can help people recover after having a stroke. The goal is to see if this program, when added to the regular care that stroke patients receive, can improve their ability to move and function. Researchers will also look at whether this program helps reduce the chances of going back to the hospital, having another stroke, or even dying.
To participate in this study, individuals need to be at least 18 years old and have been diagnosed with a stroke. They must also be cleared by a heart doctor to join the rehabilitation program and be able to safely use a special bike for exercise, either on their own or with some help. The study is currently recruiting participants, and anyone interested should be prepared to give their signed consent to join. This trial aims to provide valuable insights into the recovery process for stroke survivors.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 18 years or older
- • Stroke diagnosis (ischemic or hemorrhagic) / radiologic evidence of acute stroke
- • Medically cleared by a cardiologist for participation in the cardiac rehabilitation program with no contraindications to cardiac rehabilitation per American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR) guidelines
- • Ability to transfer on/off the recumbent bike with or without an assistive device safely, with or without assistance from another person
- • Ability to follow simple commands and communicate pain or distress
- • Admission to an Inpatient Rehabilitation Facility post-stroke
- • Signed informed consent form
- Exclusion Criteria:
- • Presence of subarachnoid hemorrhage, intracranial aneurysm, intracranial hemangioma, or arteriovenous malformation
- • Medical disorders that preclude participation in the study as determined by the Principal Investigator.
- • Inability to have baseline assessment within 60 days post-stroke diagnosis
- • Patient considered unable to comply with study requirements
- • Known terminal illness with life expectancy less than 1 year
- • Compliant diagnosis eligible for traditional cardiac rehabilitation covered by insurance
- • Unable to understand/speak English
About Hackensack Meridian Health
Hackensack Meridian Health is a leading healthcare organization based in New Jersey, dedicated to advancing medical research and improving patient care through innovative clinical trials. As a prominent sponsor of clinical research, Hackensack Meridian Health is committed to fostering collaboration between researchers, healthcare professionals, and patients to develop and evaluate cutting-edge therapies and interventions. With a focus on enhancing health outcomes and addressing pressing medical needs, the organization leverages its extensive network of hospitals, specialty care centers, and research facilities to advance clinical knowledge and contribute to the global body of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edison, New Jersey, United States
Patients applied
Trial Officials
Sara J Cuccurullo, MD
Principal Investigator
Hackensack Meridian Health - JFK Johnson Rehabilitation Institute
Talya K Fleming, MD
Principal Investigator
Hackensack Meridian Health - JFK Johnson Rehabilitation Institute
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials